Jan Prasko, Marie Ociskova, Marija Abeltina, Ilona Krone, Krystof Kantor, Jakub Vanek, Milos Slepecky, Kamila Minarikova, Petr Mozny, Monika Piliarova, Ieva Bite
Purpose: Self-awareness can be characterised as impartial, non-judgmental thoughtful attention towards the self. Self-reflection in therapy is when a therapist reviews their experiences, thoughts, and behaviours concerning therapy and changes them as needed to enhance the therapeutic process. Therapists with good quality self-reflection can make more effective and ethical decisions, differentiate their own needs from clients', understand transference and countertransference, and consider the optimal response during a session. Practising the CBT approach and reflecting on one's own experiences can be essential for successful therapeutic development. Furthermore, self-reflection forms the basis of a fruitful therapeutic relationship and the therapist's self-confidence and sense of competence.
{"title":"The importance of self-experience and self-reflection in training of cognitive behavioral therapy.","authors":"Jan Prasko, Marie Ociskova, Marija Abeltina, Ilona Krone, Krystof Kantor, Jakub Vanek, Milos Slepecky, Kamila Minarikova, Petr Mozny, Monika Piliarova, Ieva Bite","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Self-awareness can be characterised as impartial, non-judgmental thoughtful attention towards the self. Self-reflection in therapy is when a therapist reviews their experiences, thoughts, and behaviours concerning therapy and changes them as needed to enhance the therapeutic process. Therapists with good quality self-reflection can make more effective and ethical decisions, differentiate their own needs from clients', understand transference and countertransference, and consider the optimal response during a session. Practising the CBT approach and reflecting on one's own experiences can be essential for successful therapeutic development. Furthermore, self-reflection forms the basis of a fruitful therapeutic relationship and the therapist's self-confidence and sense of competence.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41172247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ivan Brychta, Alexander Mayer, Michal Gergel, Marian Vidiscak, Karol Plank
Primary hyperparathyroidism (PHPT) in pregnancy is rare and may be associated with increased maternal and fetal morbidity and mortality. The ideal timing for parathyroidectomy is during the second trimester, and parathyroidectomy in the third trimester is extremely rare. We present a case of a 32-year-old woman who was admitted to our hospital with severe hypercalcemia in the 36th week of her first pregnancy. Conventional bilateral neck exploration was performed and parathyroid adenoma was removed. The surgical procedure was tolerated well by the mother, and she delivered a healthy girl 10 days after surgery. The newborn had mild hypocalcemia that required minimal substitution postnatally; however, no tetany occurred. This case demonstrates that parathyroidectomy in the third trimester followed by spontaneous delivery may be performed safely.
{"title":"Primary hyperparathyroidism in pregnancy: a case of successful parathyroidectomy in the third trimester.","authors":"Ivan Brychta, Alexander Mayer, Michal Gergel, Marian Vidiscak, Karol Plank","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary hyperparathyroidism (PHPT) in pregnancy is rare and may be associated with increased maternal and fetal morbidity and mortality. The ideal timing for parathyroidectomy is during the second trimester, and parathyroidectomy in the third trimester is extremely rare. We present a case of a 32-year-old woman who was admitted to our hospital with severe hypercalcemia in the 36th week of her first pregnancy. Conventional bilateral neck exploration was performed and parathyroid adenoma was removed. The surgical procedure was tolerated well by the mother, and she delivered a healthy girl 10 days after surgery. The newborn had mild hypocalcemia that required minimal substitution postnatally; however, no tetany occurred. This case demonstrates that parathyroidectomy in the third trimester followed by spontaneous delivery may be performed safely.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lenka Nosakova, Peter Banovcin, Martin Duricek, Peter Uhrik, Janka Bozikova, Michal Demeter, Rudol Hyrdel
Introduction: Insulinomas are rare neuroendocrine tumors of pancreas. Clinical manifestations include various symptoms of hypoglycemia, which is the result of insulin overproduction. Symptoms of hypoglycemia are heterogenous what most probably contributes to diagnostic delay. In this study we retrospectively evaluated clinical features of hypoglycemia. We discovered that a substantial number of patients suffered from hypoglycemia unawareness.
Materials and methods: We performed retrospective analysis of prospectively collected patients with histologically confirmed insulinoma. We evaluated clinical features and signs of hypoglycemia and the duration of symptoms and performed thorough review of the patients' files in order to identify whether patients had been falsely diagnosed previously. Each patient underwent 72 hour fasting test during which levels of immunoreactive insulin (IRI), C-peptide and nadir blood glucose level were obtained. Based on the clinical findings and results of 72 hour fasting test we identified a subgroup of patients with hypoglycemia unawareness. These had an episode of clinically silent hypoglycemia. We compared IRI and C-peptide levels obtained at the time of the fasting test termination in the unawareness group and the group without hypoglycemia unawareness.
Results: Twenty two patients with insulinoma that had been hospitalized in our tertiary center were included in the analysis. Mean age was 51±16.7 years. The most common symptom reported by 63.6% of patients was fatigue, followed by increased appetite with consequent weight gain and the loss of consciousness, both reported by 40.9% of patients. Based on the review of clinical features and the results of the fasting test we identified a group of patients with hypoglycemia unawareness. We labeled the patient accordingly in case of the loss of consciousness in personal history as well as asymptomatic hypoglycemia or severe neuroglycopenic symptoms during the fasting test without any accompanying or preceding clinical signs. There were 7 patients with hypoglycemia unawareness in our cohort (31.8%). Patients with this phenomenon had significantly lower levels of both IRI (2.35±1.25 vs. 5.88±3.92ng/ml, p=0.01) and C-peptide (9.14±7.36 vs. 50±42.8 µU/ml, p=0.01) than the rest of the patients. Nadir blood glucose level during the fasting test showed no significant difference (9.4±8.2 vs. 12.2±8.2 months, p=0.28) in the unawareness group and the rest of the patients, respectively.
Conclusion: We described the phenomenon of unawareness to hypoglycemia in the patients with insulinoma. This has not been recognized in insulinoma patients yet since available evidence mostly relates to type I diabetic patients. It might lead to higher morbidity and diagnostic delay. Further studies with prospective evaluation should be performed to further confirm relatively high prevalence in patients with in
导言胰岛素瘤是一种罕见的胰腺神经内分泌肿瘤。临床表现包括各种低血糖症状,这是胰岛素分泌过多的结果。低血糖的症状多种多样,这很可能是导致诊断延误的原因。在这项研究中,我们对低血糖的临床特征进行了回顾性评估。我们发现,相当多的患者对低血糖症一无所知:我们对前瞻性收集的经组织学证实的胰岛素瘤患者进行了回顾性分析。我们评估了低血糖的临床特征和体征以及症状持续时间,并对患者档案进行了全面审查,以确定患者之前是否曾被误诊。每位患者都接受了 72 小时的空腹测试,在测试过程中获得了免疫反应性胰岛素(IRI)、C 肽和最低血糖水平。根据临床发现和 72 小时空腹测试结果,我们确定了一个低血糖无意识患者亚群。这些患者曾发生过临床上无症状的低血糖。我们比较了无低血糖意识组和无低血糖意识组在空腹测试终止时获得的 IRI 和 C 肽水平:分析对象包括在本三级医疗中心住院治疗的 22 名胰岛素瘤患者。平均年龄为 51±16.7 岁。63.6%的患者报告的最常见症状是疲劳,其次是食欲增加导致体重增加和意识丧失,这两种症状均有40.9%的患者报告。根据临床特征和空腹测试结果,我们确定了一组低血糖无意识症患者。如果患者在个人病史中出现意识丧失、无症状性低血糖或在空腹测试中出现严重的神经性低血糖症状,但没有任何伴随或先兆临床症状,我们就会给患者贴上相应的标签。我们的队列中有 7 名低血糖无意识患者(31.8%)。与其他患者相比,有这种现象的患者的 IRI(2.35±1.25 vs. 5.88±3.92ng/ml,p=0.01)和 C 肽(9.14±7.36 vs. 50±42.8 µU/ml,p=0.01)水平明显较低。无意识组与其他患者在空腹测试期间的原始血糖水平无明显差异(9.4±8.2 vs. 12.2±8.2个月,P=0.28):我们描述了胰岛素瘤患者对低血糖不自知的现象。由于现有证据大多与 I 型糖尿病患者有关,因此这种现象尚未在胰岛素瘤患者中得到认可。这可能会导致更高的发病率和诊断延误。应进一步开展前瞻性评估研究,以进一步确认胰岛素瘤患者中相对较高的患病率。
{"title":"Phenomenon of hypoglycemia unawareness in patients with insulinoma - single center experience.","authors":"Lenka Nosakova, Peter Banovcin, Martin Duricek, Peter Uhrik, Janka Bozikova, Michal Demeter, Rudol Hyrdel","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Insulinomas are rare neuroendocrine tumors of pancreas. Clinical manifestations include various symptoms of hypoglycemia, which is the result of insulin overproduction. Symptoms of hypoglycemia are heterogenous what most probably contributes to diagnostic delay. In this study we retrospectively evaluated clinical features of hypoglycemia. We discovered that a substantial number of patients suffered from hypoglycemia unawareness.</p><p><strong>Materials and methods: </strong>We performed retrospective analysis of prospectively collected patients with histologically confirmed insulinoma. We evaluated clinical features and signs of hypoglycemia and the duration of symptoms and performed thorough review of the patients' files in order to identify whether patients had been falsely diagnosed previously. Each patient underwent 72 hour fasting test during which levels of immunoreactive insulin (IRI), C-peptide and nadir blood glucose level were obtained. Based on the clinical findings and results of 72 hour fasting test we identified a subgroup of patients with hypoglycemia unawareness. These had an episode of clinically silent hypoglycemia. We compared IRI and C-peptide levels obtained at the time of the fasting test termination in the unawareness group and the group without hypoglycemia unawareness.</p><p><strong>Results: </strong>Twenty two patients with insulinoma that had been hospitalized in our tertiary center were included in the analysis. Mean age was 51±16.7 years. The most common symptom reported by 63.6% of patients was fatigue, followed by increased appetite with consequent weight gain and the loss of consciousness, both reported by 40.9% of patients. Based on the review of clinical features and the results of the fasting test we identified a group of patients with hypoglycemia unawareness. We labeled the patient accordingly in case of the loss of consciousness in personal history as well as asymptomatic hypoglycemia or severe neuroglycopenic symptoms during the fasting test without any accompanying or preceding clinical signs. There were 7 patients with hypoglycemia unawareness in our cohort (31.8%). Patients with this phenomenon had significantly lower levels of both IRI (2.35±1.25 vs. 5.88±3.92ng/ml, p=0.01) and C-peptide (9.14±7.36 vs. 50±42.8 µU/ml, p=0.01) than the rest of the patients. Nadir blood glucose level during the fasting test showed no significant difference (9.4±8.2 vs. 12.2±8.2 months, p=0.28) in the unawareness group and the rest of the patients, respectively.</p><p><strong>Conclusion: </strong>We described the phenomenon of unawareness to hypoglycemia in the patients with insulinoma. This has not been recognized in insulinoma patients yet since available evidence mostly relates to type I diabetic patients. It might lead to higher morbidity and diagnostic delay. Further studies with prospective evaluation should be performed to further confirm relatively high prevalence in patients with in","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Our dear Professor, the Editor-in-Chief of Neuroendocrinology Letters (NEL) has left us. We, the Editors, Associated Editors and the Editorial Board continue our work without interruption and will follow the steps and traditions established by Professor Fedor-Freybergh, point to point, without exception. As it was, so will it be. On this sad occasion, we would like to reproduce some excerpts from an article published in Activitas Nervosa Superior Rediviva (ANSR), on the occasion of Professor Fedor-Freybergh's 80th birthday: "Let us to note - at least telegraphically - the profound milestones in his professional curriculum: Doctor of Medicine (1959); Doctor of Psychology (1965), Certificate in Psychiatry (1962) all 3 from Comenius University in Bratislava; Certificate in Pedopsychiatry (1965) and PhD in Psychiatry (1967) both from Charles University in Prague); Certificate and Doctorate in Obstetrics and Gynaecology (1977 Sweden); since 1968 appointments in Psychiatric Clinics in Austria, Switzerland, England, Sweden and Czech Republic; in 1974, he read the Introductory Lecture Psychotropic Action of Hormones at the 1st World Congress of Biological Psychiatry in Buenos Aires which significantly contributed to the global development of this discipline in both educational and scientific fields, Lecturer in Psycho-neuroendocrinology 1978 and in 1982 appointed the 1st University Professor in Europe in this field (University of Salzburg);. In 1978 Professor Fedor-Freybergh founded and Edited the peer reviewed International Journal of Prenatal and Perinatal Psychology and Medicine; in 1986, he elevated the International Study-Group for Prenatal Psychology to transform into the International Society of Prenatal and Perinatal Psychology & Medicine, in 1988, he published in English and German languages the world's first textbook Prenatal & Perinatal Psychology & Medicine; from 1983-1992 he served as Elected President of the International Society of Prenatal Psychology and Medicine and since 1992 as its Honorary Life President; in 1996, he won an audition for the post of Professor of Child Psychiatry at the 3rd Medical Faculty of Charles University in Prague which he held until 2004; in 1997 he became Director of the Institute of Prenatal and Perinatal Psychology, Medicine and Social Work at the University of Health and Social Work of St. Elisabeth University in Bratislava, in 2009, the Rector of the University granted Prof. Fedor-Freybergh the title of Professor of Prenatal and Perinatal Psychology and Medicine - the first such Professorship in the world". "As the Editor-in-Chief of ANSR [besides Neuroendocrinology Letters, Editors note], he became a member of the CIANS Executive Committee and actively participated in CIANS' international conferences and symposia. In recent years, his health has not allowed him to travel, but he has not stopped watching these events. In face-to-face meetings, we discussed much of the knowledge presented. Discussing w
{"title":"Prof. Peter G. FEDOR-FREYBERGH, MD, DSc, Dr.h.c. mult.","authors":"L Maas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Our dear Professor, the Editor-in-Chief of Neuroendocrinology Letters (NEL) has left us. We, the Editors, Associated Editors and the Editorial Board continue our work without interruption and will follow the steps and traditions established by Professor Fedor-Freybergh, point to point, without exception. As it was, so will it be. On this sad occasion, we would like to reproduce some excerpts from an article published in Activitas Nervosa Superior Rediviva (ANSR), on the occasion of Professor Fedor-Freybergh's 80th birthday: \"Let us to note - at least telegraphically - the profound milestones in his professional curriculum: Doctor of Medicine (1959); Doctor of Psychology (1965), Certificate in Psychiatry (1962) all 3 from Comenius University in Bratislava; Certificate in Pedopsychiatry (1965) and PhD in Psychiatry (1967) both from Charles University in Prague); Certificate and Doctorate in Obstetrics and Gynaecology (1977 Sweden); since 1968 appointments in Psychiatric Clinics in Austria, Switzerland, England, Sweden and Czech Republic; in 1974, he read the Introductory Lecture Psychotropic Action of Hormones at the 1st World Congress of Biological Psychiatry in Buenos Aires which significantly contributed to the global development of this discipline in both educational and scientific fields, Lecturer in Psycho-neuroendocrinology 1978 and in 1982 appointed the 1st University Professor in Europe in this field (University of Salzburg);. In 1978 Professor Fedor-Freybergh founded and Edited the peer reviewed International Journal of Prenatal and Perinatal Psychology and Medicine; in 1986, he elevated the International Study-Group for Prenatal Psychology to transform into the International Society of Prenatal and Perinatal Psychology & Medicine, in 1988, he published in English and German languages the world's first textbook Prenatal & Perinatal Psychology & Medicine; from 1983-1992 he served as Elected President of the International Society of Prenatal Psychology and Medicine and since 1992 as its Honorary Life President; in 1996, he won an audition for the post of Professor of Child Psychiatry at the 3rd Medical Faculty of Charles University in Prague which he held until 2004; in 1997 he became Director of the Institute of Prenatal and Perinatal Psychology, Medicine and Social Work at the University of Health and Social Work of St. Elisabeth University in Bratislava, in 2009, the Rector of the University granted Prof. Fedor-Freybergh the title of Professor of Prenatal and Perinatal Psychology and Medicine - the first such Professorship in the world\". \"As the Editor-in-Chief of ANSR [besides Neuroendocrinology Letters, Editors note], he became a member of the CIANS Executive Committee and actively participated in CIANS' international conferences and symposia. In recent years, his health has not allowed him to travel, but he has not stopped watching these events. In face-to-face meetings, we discussed much of the knowledge presented. Discussing w","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139748002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and aims: An ulcerative colitis rat model was established with baicalin as the treatment.
Materials and methods: Quantitative real-time polymerase chain reaction (QRT-PCR) and Western blot analysis were used to determine inflammatory factor expression in interstitial cells of Cajal.
Results: Baicalin treatment reduced the ulcerative colitis symptoms, such as bloody diarrhea, reduction in body weight, and vomiting. Baicalin treatment decreased the serum levels of tumor necrosis factor α (TNFα), interleukin (IL)-1β, and IL-17A compared to the phosphate buffer saline (PBS) control group. Baicalin treatment protected the interstitial cells of Cajal against oxidative stress injury via improvements in superoxide dismutase (SOD) activity, modified disease activity index (mDAI), reactive oxygen species (ROS) production, catalase (CAT), glutathione (GSH), and nitric oxide (NO) level in the serum and interstitial cells of Cajal. Baicalin treatment decreased apoptosis of interstitial cells of Cajal. Baicalin treatment decreased the nuclear factor Kappa B (NF-κB)/ Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)/ extracellular regulated kinase (Erk) / protein kinase B (Akt) signal pathway in interstitial cells of Cajal and NF-κB overexpression abrogated the decreased baicalin-induced inflammation and apoptosis of interstitial cells of Cajal induced.
Conclusion: Baicalin treatment improved ulcerative colitis symptoms and decreased inflammation and apoptosis of interstitial cells of Cajal. Baicalin treatment inhibited inflammation and apoptosis of interstitial cells of Cajal by targeting the NF-κB pathway in an ulcerative colitis rat model, which may serve as a potential agent for the treatment of ulcerative colitis.
{"title":"Baicalin inhibits inflammation and apoptosis of interstitial cells of Cajal by targeting the NF-κB-mediated AMPK/Erk/Akt pathway in an ulcerative colitis rat model.","authors":"Wei-Ping Bi, Hui-Bin Man","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and aims: </strong>An ulcerative colitis rat model was established with baicalin as the treatment.</p><p><strong>Materials and methods: </strong>Quantitative real-time polymerase chain reaction (QRT-PCR) and Western blot analysis were used to determine inflammatory factor expression in interstitial cells of Cajal.</p><p><strong>Results: </strong>Baicalin treatment reduced the ulcerative colitis symptoms, such as bloody diarrhea, reduction in body weight, and vomiting. Baicalin treatment decreased the serum levels of tumor necrosis factor α (TNFα), interleukin (IL)-1β, and IL-17A compared to the phosphate buffer saline (PBS) control group. Baicalin treatment protected the interstitial cells of Cajal against oxidative stress injury via improvements in superoxide dismutase (SOD) activity, modified disease activity index (mDAI), reactive oxygen species (ROS) production, catalase (CAT), glutathione (GSH), and nitric oxide (NO) level in the serum and interstitial cells of Cajal. Baicalin treatment decreased apoptosis of interstitial cells of Cajal. Baicalin treatment decreased the nuclear factor Kappa B (NF-κB)/ Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)/ extracellular regulated kinase (Erk) / protein kinase B (Akt) signal pathway in interstitial cells of Cajal and NF-κB overexpression abrogated the decreased baicalin-induced inflammation and apoptosis of interstitial cells of Cajal induced.</p><p><strong>Conclusion: </strong>Baicalin treatment improved ulcerative colitis symptoms and decreased inflammation and apoptosis of interstitial cells of Cajal. Baicalin treatment inhibited inflammation and apoptosis of interstitial cells of Cajal by targeting the NF-κB pathway in an ulcerative colitis rat model, which may serve as a potential agent for the treatment of ulcerative colitis.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Robin Sín, Dalibor Sedlacek, Patrik Christian Cmorej, David Peran, David Peran, David Peran, David Peran
COVID-19 disease is caused by the new coronavirus SARS-CoV-2. The disease first appeared in China in 2019 and quickly spread throughout the world. It primarily affects the respiratory tract, manifested by fever, cough and the development of dyspnoea, but the symptoms and complications can affect any organ system. Neurological symptoms include headaches, muscle and joint pain, taste and smell disorders. Complications include inflammatory diseases of the central nervous system, ataxia, peripheral nerve and muscle diseases, worsening of extrapyramidal diseases, and neuropsychiatric disorders. This paper presents a case report of a 62-year-old man with cerebellar syndrome, ataxia, intentional tremor and hypermetria when dealing with COVID-19 disease.
{"title":"Cerebellar syndrome as a complication of COVID-19 disease.","authors":"Robin Sín, Dalibor Sedlacek, Patrik Christian Cmorej, David Peran, David Peran, David Peran, David Peran","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>COVID-19 disease is caused by the new coronavirus SARS-CoV-2. The disease first appeared in China in 2019 and quickly spread throughout the world. It primarily affects the respiratory tract, manifested by fever, cough and the development of dyspnoea, but the symptoms and complications can affect any organ system. Neurological symptoms include headaches, muscle and joint pain, taste and smell disorders. Complications include inflammatory diseases of the central nervous system, ataxia, peripheral nerve and muscle diseases, worsening of extrapyramidal diseases, and neuropsychiatric disorders. This paper presents a case report of a 62-year-old man with cerebellar syndrome, ataxia, intentional tremor and hypermetria when dealing with COVID-19 disease.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bozena Markovic Baluchova, Peter Bačík, Alexandra Mamova
Background: A significant proportion of anthropogenic dust particles are present in the atmosphere. In particular, these include industrial and municipal dust, black carbon from fossil fuels and biomass. Mineralogical research of dust particles in the air is important for knowing their impact on public health in hazardous work environments (not only in Slovakia). In the recent past (in 2000-2010), research of dust fallouts from mining and processing of mineral resources was carried out. Specifically, it was focused on the Lubeník and Jelšava area, where the environment and population were adversely affected by mining activities and magnesite (MgCO3) processing treatment.
Methods: The dust obtained from the plastic containers at the sampling stations was filtered in distilled-water wash. Afterwards the dust dispersion, respirable fraction and chemical composition were determined by analytical methods. The mineralogical characteristics of the particles were determined by X-ray powder diffraction (XRD) and their morphology by Scanning electron microscopy (SEM).
Results: The exposure to dust particles and associated contaminants can cause pulmonary diseases with a significant impact on the inhabitants health and quality of life. The most destructive action of the mineral dust particles comes after their penetration into the alveolar parts of the lungs. Pulmonary dusting, Pneumoconiosis, occurs, when the fibrogenic dust particles smaller than 2.5 µm passes through the alveolar wall into the interstitial space. Insoluble or sparingly soluble minerals are referred to as active, they initiate and activate fibrosis. In the samples from Jelšava-Lubeník, the dominant mineral phases include magnesite occurring as crystals and their fragments and periclase present as irregular allotriomorphic grains, aggregates and masses. According to dusting monitoring, a trend of decreasing in the periclase proportion was observed.
Conclusions: Mineral composition and morphology of dust fallouts in the air from mining areas directly affects the health of the population and contributes to the increased incidence of respiratory diseases in the region, even several years after closing the mines or after the change of filters in mineral processing plants. Reducing unwanted air pollution should be a priority for relevant ministries (of health, environment etc.), as well as a challenge for public health professionals.
背景:大气中存在很大一部分人为尘埃粒子。其中特别包括工业和城市粉尘、化石燃料和生物质产生的黑碳。对空气中的粉尘颗粒进行矿物学研究,对于了解其在危险工作环境(不仅在斯洛伐克)中对公众健康的影响非常重要。近期(2000-2010 年),对矿产资源开采和加工过程中产生的粉尘进行了研究。具体而言,研究主要集中在卢贝尼克(Lubeník)和耶尔萨瓦(Jelšava)地区,那里的环境和人口受到采矿活动和菱镁矿(MgCO3)加工处理的不利影响:取样站塑料容器中的粉尘经蒸馏水洗涤过滤。然后用分析方法测定粉尘的分散度、可吸入部分和化学成分。通过 X 射线粉末衍射(XRD)和扫描电子显微镜(SEM)确定了颗粒的矿物学特征:接触粉尘颗粒和相关污染物会导致肺部疾病,对居民的健康和生活质量产生重大影响。矿物粉尘颗粒的最大破坏作用是在其渗入肺泡部分之后。当小于 2.5 微米的纤维尘粒穿过肺泡壁进入肺间质时,就会发生肺尘埃沉着症。不溶性或少溶性矿物质被称为活性矿物质,它们会引发和激活纤维化。在 Jelšava-Lubeník 的样本中,主要矿物相包括以晶体及其碎片形式出现的菱镁矿,以及以不规则异形颗粒、聚集体和块状形式出现的珍珠岩。根据粉尘监测,观察到珍珠岩比例呈下降趋势:结论:矿区空气中粉尘的矿物成分和形态直接影响着居民的健康,并导致该地区呼吸道疾病发病率的上升,即使在矿山关闭或选矿厂更换过滤器数年后也是如此。减少不必要的空气污染应成为相关部委(卫生部、环境部等)的优先事项,也是公共卫生专业人员面临的挑战。
{"title":"The Health Impact of Mineral Dust Air Pollution on the Global and Local Scale (on the example from Slovakia).","authors":"Bozena Markovic Baluchova, Peter Bačík, Alexandra Mamova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>A significant proportion of anthropogenic dust particles are present in the atmosphere. In particular, these include industrial and municipal dust, black carbon from fossil fuels and biomass. Mineralogical research of dust particles in the air is important for knowing their impact on public health in hazardous work environments (not only in Slovakia). In the recent past (in 2000-2010), research of dust fallouts from mining and processing of mineral resources was carried out. Specifically, it was focused on the Lubeník and Jelšava area, where the environment and population were adversely affected by mining activities and magnesite (MgCO3) processing treatment.</p><p><strong>Methods: </strong>The dust obtained from the plastic containers at the sampling stations was filtered in distilled-water wash. Afterwards the dust dispersion, respirable fraction and chemical composition were determined by analytical methods. The mineralogical characteristics of the particles were determined by X-ray powder diffraction (XRD) and their morphology by Scanning electron microscopy (SEM).</p><p><strong>Results: </strong>The exposure to dust particles and associated contaminants can cause pulmonary diseases with a significant impact on the inhabitants health and quality of life. The most destructive action of the mineral dust particles comes after their penetration into the alveolar parts of the lungs. Pulmonary dusting, Pneumoconiosis, occurs, when the fibrogenic dust particles smaller than 2.5 µm passes through the alveolar wall into the interstitial space. Insoluble or sparingly soluble minerals are referred to as active, they initiate and activate fibrosis. In the samples from Jelšava-Lubeník, the dominant mineral phases include magnesite occurring as crystals and their fragments and periclase present as irregular allotriomorphic grains, aggregates and masses. According to dusting monitoring, a trend of decreasing in the periclase proportion was observed.</p><p><strong>Conclusions: </strong>Mineral composition and morphology of dust fallouts in the air from mining areas directly affects the health of the population and contributes to the increased incidence of respiratory diseases in the region, even several years after closing the mines or after the change of filters in mineral processing plants. Reducing unwanted air pollution should be a priority for relevant ministries (of health, environment etc.), as well as a challenge for public health professionals.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The aim of this study is to point out certain discrepancies and inaccuracies in reporting data concerning the consumption of cardiovascular pharmaceuticals (Anatomical Therapeutic Chemical code C, cardiovascular system) - measured in defined daily doses (DDDs) per 1,000 inhabitants per day - as reported by the Slovak Republic and the Czech Republic for the year 2014. This data also appears in the online database of the Organization for Economic Co-operation and Development (OECD) Health Statistics.
Methods: First, we take the Czech wholesalers' data by DDD as reported to the OECD, and we compare this Czech data with the Slovak data. We calculate the Slovak data by the method traditionally used in the Slovak Republic (SDS - standard dose of substance). However, the data we use for the Slovak Republic is that reported by health insurance companies and hospital pharmacies, while the official data reported to the OECD is based on wholesalers' reports. Secondly, we recalculate medicine consumption for both countries using DDD.
Results: A comparison based on the first methodological approach shows the Slovak Republic having a higher consumption of cardiovascular medicines than the Czech Republic. A second comparison, using the same measurement tool (DDD) for both countries, shows cardiovascular medicine consumption to be actually lower in the Slovak Republic as compared to the Czech Republic.
Conclusion: Our results indicate that, when actual DDDs for both countries are used, cardiovascular pharmaceutical consumption in the Slovak Republic is shown to be lower than in the Czech Republic.
{"title":"Slovak and Czech OECD Data under the Magnifying Glass: Cardiovascular Pharmaceutical Consumption by Defined Daily Dose.","authors":"Petra Szilágyiová, Jana Slušná, Robert Babela","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to point out certain discrepancies and inaccuracies in reporting data concerning the consumption of cardiovascular pharmaceuticals (Anatomical Therapeutic Chemical code C, cardiovascular system) - measured in defined daily doses (DDDs) per 1,000 inhabitants per day - as reported by the Slovak Republic and the Czech Republic for the year 2014. This data also appears in the online database of the Organization for Economic Co-operation and Development (OECD) Health Statistics.</p><p><strong>Methods: </strong>First, we take the Czech wholesalers' data by DDD as reported to the OECD, and we compare this Czech data with the Slovak data. We calculate the Slovak data by the method traditionally used in the Slovak Republic (SDS - standard dose of substance). However, the data we use for the Slovak Republic is that reported by health insurance companies and hospital pharmacies, while the official data reported to the OECD is based on wholesalers' reports. Secondly, we recalculate medicine consumption for both countries using DDD.</p><p><strong>Results: </strong>A comparison based on the first methodological approach shows the Slovak Republic having a higher consumption of cardiovascular medicines than the Czech Republic. A second comparison, using the same measurement tool (DDD) for both countries, shows cardiovascular medicine consumption to be actually lower in the Slovak Republic as compared to the Czech Republic.</p><p><strong>Conclusion: </strong>Our results indicate that, when actual DDDs for both countries are used, cardiovascular pharmaceutical consumption in the Slovak Republic is shown to be lower than in the Czech Republic.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrik Christian Cmorej, Marcel Nesvadba, Alexandra Mamova, Robert Babela, David Peran, Jaroslav Pekara, Alena Kohlova, Petr Bures Bures, Jan Trpisovsky, Otakar Fleishmann, Eva Pfefferova
The increasing number of patients with anaphylactic reactions is a modern challenge for healthcare professionals in clinical practice and public health professionals. It remains difficult to determine the prevalence or incidence of anaphylaxis in the population due to the long absence of a consensus definition, the fact that analyses are performed on various population groups and the use of different data collection methodologies. In the United States, anaphylaxis mortality ranges from 0.63 to 0.76 cases per million inhabitants, with 58% of these deaths due to drug anaphylaxis. The risk factors for anaphylaxis are ramipril and metoprolol use, which is common in patients with cardiovascular disease. Also, a higher level of gliadin following excess gluten intake is associated with a higher incidence of anaphylaxis. Drugs, food and insect stings have long been known as anaphylaxis inductors. In diagnosis, determination of serum tryptase concentration is used. In patients with normal tryptase concentration, it is appropriate to screen other inflammatory mediators. The authors of this article present new findings on anaphylaxis in the literature and recommended practices of professional societies in the context of public health.
{"title":"Anaphylaxis in Public Health.","authors":"Patrik Christian Cmorej, Marcel Nesvadba, Alexandra Mamova, Robert Babela, David Peran, Jaroslav Pekara, Alena Kohlova, Petr Bures Bures, Jan Trpisovsky, Otakar Fleishmann, Eva Pfefferova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The increasing number of patients with anaphylactic reactions is a modern challenge for healthcare professionals in clinical practice and public health professionals. It remains difficult to determine the prevalence or incidence of anaphylaxis in the population due to the long absence of a consensus definition, the fact that analyses are performed on various population groups and the use of different data collection methodologies. In the United States, anaphylaxis mortality ranges from 0.63 to 0.76 cases per million inhabitants, with 58% of these deaths due to drug anaphylaxis. The risk factors for anaphylaxis are ramipril and metoprolol use, which is common in patients with cardiovascular disease. Also, a higher level of gliadin following excess gluten intake is associated with a higher incidence of anaphylaxis. Drugs, food and insect stings have long been known as anaphylaxis inductors. In diagnosis, determination of serum tryptase concentration is used. In patients with normal tryptase concentration, it is appropriate to screen other inflammatory mediators. The authors of this article present new findings on anaphylaxis in the literature and recommended practices of professional societies in the context of public health.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In 2019, there were several new epidemics of diseases around the world, which would only be known from old medical books. Conspiracy and antivax movements around the world have raised important issues about public health, its safety, prevention and the media. The importance of public health is increasing more than ever. That is why we are very pleased that we have succeeded in collecting enough quality articles to present a collection of papers this year again. We have a great need for quality data to combat disinformation, hoaxes and lies. But we also have a greater need to deliver this information to medically untrained people. We - doctors, nurses and medical workers - have lost our ability to talk to people, talk to them in ways they can actually understand us. This, and lack of time for patients, has brought us to this situation and only patience, good data and easily understandable language can give us success. We also have an important task to renew people's trust in doctors and to humanize modern medicine. So, together with the fight against epidemics, setting new standards for occupational safety or ensuring healthy habits for children, adults and the elderly, we should not forget to communicate in the first place. We are grateful for the opportunity to provide you with this supplemental issue of Neuroendocrinology Letters, where support for public health issues has always been strong.
{"title":"Selected topics in public health - Editorial.","authors":"Alexandra Mamova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 2019, there were several new epidemics of diseases around the world, which would only be known from old medical books. Conspiracy and antivax movements around the world have raised important issues about public health, its safety, prevention and the media. The importance of public health is increasing more than ever. That is why we are very pleased that we have succeeded in collecting enough quality articles to present a collection of papers this year again. We have a great need for quality data to combat disinformation, hoaxes and lies. But we also have a greater need to deliver this information to medically untrained people. We - doctors, nurses and medical workers - have lost our ability to talk to people, talk to them in ways they can actually understand us. This, and lack of time for patients, has brought us to this situation and only patience, good data and easily understandable language can give us success. We also have an important task to renew people's trust in doctors and to humanize modern medicine. So, together with the fight against epidemics, setting new standards for occupational safety or ensuring healthy habits for children, adults and the elderly, we should not forget to communicate in the first place. We are grateful for the opportunity to provide you with this supplemental issue of Neuroendocrinology Letters, where support for public health issues has always been strong.</p>","PeriodicalId":94154,"journal":{"name":"Neuro endocrinology letters","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}